immunology

    Cards (25)

    • Antigen
      a protein molecule that stimulates an immune response resulting in the production of specific antibodies
    • pathogens
      microorganisms that cause diseases by :
      - damaging body cells
      - releasing toxins that damage body cells
    • non specific immune response

      immediate and same for all pathogens
      1. physical barrier
      2. phagocytosis
    • physical barriers
      lungs - mucus membrane
      oesophagus - cilia
      lysozymes (hydrolytic enzymes) in tears and saliva
      skin
    • phagocytosis - DIPFDD
      Detection - phagocyte detects the pathogen as attracted to chemicals release
      Ingestion - phagocyte engulfs pathogen
      Phagosome forms
      Fuses with lysosome containing lysosymes forming phagolysosome
      Digestion - lysozymes hydrolyse the pathogens
      Discharge - waste released (some antigens presented on cell) exocytosis
    • Antigen Presenting cells

      phagocyte present antigens on its cell membrane become APC which can bring about SPECIFIC immune response
    • Antibody
      a protein with a variable region has specific amino acid sequence. the tertiary structure of the binding site is complementary to antigens.
      produced by plasma cells
    • Antigen- Antibody complexes.

      Antibody binding site is complementary to antigen to form an antigen antibody complexes. this lead to agglutination and phagocytes may then digest many pathogens at the same time.
    • Cell mediated response

      T cells bind to antigen presenting cell and activates
      T cell divides by mitosis/ clonal selection
      cells differentiate into = cytotoxic T cells, or T helper cells
      Cytotoxic T cells = release perforin that puts holes into cell membrane
      T helper cells = activate B cells
    • Humoral response

      T helper cells stimulate B cells
      B cell divides by mitosis/ clonal selection
      differentiate into plasma cells or memory cells
      plasma cells = release antibodies specific to antigen to destroy pathogens
      memory cells = stay in body in case of future infection by the same pathogen with same antigen
    • secondary immune response

      the activation of memory cells to produce antibodies = secondary
      SIR is when the body is exposed to same a pathogen with the same antigens a 2nd time
      memory cells makes secondary immune response both quicker and produces more antibodies , more extensive
    • antigenic variability

      when antigens mutate and change shape, making it difficult to develop vaccines against these pathogens
      when this occurs the receptors on memory cell dont recognise the pathogen
      the antibodies are no longer complimentary
      so have to go through specific and non specific immune response again = longer process
    • types of immunity
      active and passive
    • active immunity

      in response to an infection or vaccination
      exposed to antigen
      memory cells produced
      antibodies produced
      long term
      slow acting (has to go through full primary immune response)
    • passive immunity

      after you receive antibodies from someone or somewhere
      no exposure to antigen
      no memory cells
      antibodies from outside the body
      short term
      fast acting
    • Vaccine
      contains antigens from a dead or weakened pathogen to stimulate the production of antibodies and memory cells
      vaccines are not effective against pathogens that show antigenic variability
    • vaccine process

      1. vaccine contains antigen from pathogen
      2. displayed on APC
      3. T cell binds to antigen on APC & activates
      4. divides by mitosis into t helper
      6. T helper stimulates B cells
      7. B cell divides by mitosis to give plasma cells
      8. Plasma cell produces/ secretes antibody
      9. antibodies destroy pathogens
      Upon reinfection - memory cells allow for rapid production of antibodies
    • vaccination ethics

      cause side effects
      autonomy - decision of individual
      devlopment and testing on animals = infringe rights of animals?
      available to everyone or just those who can afford it?
      loss of genetic variability
      human testing = who should be tested/ is it a risk?
    • HIV
      viral replication -
      viral proteins bind to receptors on t helper cell
      membranes fuse
      reverse transcriptase creates viral rna in dna
      viral dna integrates with host dna
      transcription and translation occurs creating viral proteins
      proteins appear on t helper cell surface
      reassembly of virus
      budding occurs
    • what happens to t helper cells because of HIV

      t helper cell numbers decrease overtime
      therefore humoral response can not occur so no antibodies can be prodced
      the immune system is then weakened
    • AIDS (acquired immune deficiency syndrome)

      symptoms are - low numbers of T helper cells
      one or more infections
      increase risk of developing cancer
      severe body wasting
      and can lead to death
    • monoclonal antibodies

      made by the same B cell so are all sepcific to one type of antibody
      used for - research, immunoassays
    • monoclonal antibodies in cancer treatment

      be made t bind to antigens of blood clots/ cancer cells
      easy to see where they have built up in the body
      attach to specific proteins produced by cells
      cancer cells have diff proteins on surface to non cancer cells
      comp antibodies to cancers can also have anti cancer drugs on the surface
      fewer side effects as only target cancer cells not nncancerous cells
    • monoclonal antibodies in pregnancy tests

      complimentary to hcg hormone
      if pregnant then woman will have hcg hormones
      MA can bind to hcg and see if your pregnant
    • ELISA (enzyme-linked immunosorbent assay)

      used to detect and quantify substance
      1. coat the well with antigen
      then wash to remove any unbound antigen
      2. add patients blood sample and if infected with specific pathogen they will hhave produced antigen- antibody complexes
      then wash to remove blood plasma and unbound antibody
      3. add enzyme linked antibody that will bind to already binded antibody
      then wash to remove any unbound enzyme linked antibody
      4. add substrate and if A-A complexes are present the enzyme on the enzyme linked atibody will cause substrate to change colour